Africa HIV Treatment Drugs Market 2023-2027
Description
HIV Treatment Drugs Market in Africa 2023-2027
Technavio has been monitoring the HIV treatment drugs market in Africa and it is poised to grow by $321.6 mn during 2023-2027, accelerating at a CAGR of 3.76% during the forecast period. Our report on the HIV treatment drugs market in Africa provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of STDs, favorable international programs, and government collaborations.
Technavio's HIV treatment drugs market in Africa is segmented as below:
By Drug Class
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on HIV treatment drugs market in Africa covers the following areas:
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Technavio has been monitoring the HIV treatment drugs market in Africa and it is poised to grow by $321.6 mn during 2023-2027, accelerating at a CAGR of 3.76% during the forecast period. Our report on the HIV treatment drugs market in Africa provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of STDs, favorable international programs, and government collaborations.
Technavio's HIV treatment drugs market in Africa is segmented as below:
By Drug Class
- Reverse transcriptase inhibitors
- Protease inhibitors
- Integrase inhibitors
- Fusion inhibitors
- Coreceptor antagonists
- Oral drugs
- Injectable drugs
- South Africa
- Nigeria
- Kenya
- Uganda
- Rest of Africa
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on HIV treatment drugs market in Africa covers the following areas:
- HIV treatment drugs market sizing
- HIV treatment drugs market forecast
- HIV treatment drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
120 Pages
- Market overview
- Market ecosystem
- Market definition
- Market segment analysis
- Market size 2022
- Market outlook: Forecast for 2022-2027
- HIV treatment drugs market in Africa 2017 - 2021
- Drug Class Segment Analysis 2017 - 2021
- Route Of Administration Segment Analysis 2017 - 2021
- Country Segment Analysis 2017 - 2021
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Drug Class
- Reverse transcriptase inhibitors - Market size and forecast 2022-2027
- Protease inhibitors - Market size and forecast 2022-2027
- Integrase inhibitors - Market size and forecast 2022-2027
- Fusion inhibitors - Market size and forecast 2022-2027
- Coreceptor antagonists - Market size and forecast 2022- 2027
- Market opportunity by Drug Class
- Market segments
- Comparison by Route of Administration
- Oral drugs - Market size and forecast 2022-2027
- Injectable drugs - Market size and forecast 2022-2027
- Market opportunity by Route of Administration
- Customer landscape overview
- Geographic segmentation
- Geographic comparison
- South Africa - Market size and forecast 2022-2027
- Nigeria - Market size and forecast 2022-2027
- Kenya - Market size and forecast 2022-2027
- Uganda - Market size and forecast 2022-2027
- Rest of Africa - Market size and forecast 2022-2027
- Market opportunity by geography
- Market drivers
- Market challenges
- Impact of drivers and challenges
- Market trends
- Overview
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- AbbVie Inc.
- Alpha Pharma
- Aspen Pharmacare Holdings Ltd.
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Avacare Health
- Cipla Ltd.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Merck and Co. Inc.
- Sun Pharmaceutical Industries Ltd.
- Theratechnologies Inc.
- Viatris Inc.
- Scope of the report
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
